Cargando…

Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice

BACKGROUND: It is widely accepted that mitochondria have a direct impact on neuronal function and survival. Oxidative stress caused by mitochondrial abnormalities play an important role in the pathophysiology of lipopolysaccharide (LPS)-induced memory impairment. Elamipretide (SS-31) is a novel mito...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Weixing, Xu, Zhipeng, Cao, Jiangbei, Fu, Qiang, Wu, Yishuang, Zhang, Xiaoying, Long, Yue, Zhang, Xuan, Yang, Yitian, Li, Yunfeng, Mi, Weidong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865061/ https://www.ncbi.nlm.nih.gov/pubmed/31747905 http://dx.doi.org/10.1186/s12974-019-1627-9

Ejemplares similares

Elamipretide (SS-31) Improves Functional Connectivity in Hippocampus and Other Related Regions Following Prolonged Neuroinflammation Induced by Lipopolysaccharide in Aged Rats
por: Liu, Yang, et al.
Publicado: (2021)

The effects of a mitochondrial targeted peptide (elamipretide/SS31) on BAX recruitment and activation during apoptosis
por: Grosser, Joshua A., et al.
Publicado: (2021)

Elamipretide (SS-31) Ameliorates Isoflurane-Induced Long-Term Impairments of Mitochondrial Morphogenesis and Cognition in Developing Rats
por: Wu, Jing, et al.
Publicado: (2017)

The mitochondrially targeted peptide elamipretide (SS-31) improves ADP sensitivity in aged mitochondria by increasing uptake through the adenine nucleotide translocator (ANT)
por: Pharaoh, Gavin, et al.
Publicado: (2023)

Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide
por: Sabbah, Hani N.
Publicado: (2020)

Elamipretide Improves Mitochondrial Function in the Failing Human Heart
por: Chatfield, Kathryn C., et al.
Publicado: (2019)

Effects of elamipretide on skeletal muscle in dogs with experimentally induced heart failure
por: Sabbah, Hani N., et al.
Publicado: (2019)

Elamipretide Attenuates Pyroptosis and Perioperative Neurocognitive Disorders in Aged Mice
por: Zuo, Youmei, et al.
Publicado: (2020)

Effects of Elamipretide on Autophagy in Renal Cells of Pigs with Metabolic Syndrome
por: Hong, Siting, et al.
Publicado: (2022)

Elamipretide effects on the skeletal muscle phosphoproteome in aged female mice
por: Campbell, Matthew D., et al.
Publicado: (2022)

Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy
por: Karaa, Amel, et al.
Publicado: (2018)

A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy
por: Karaa, Amel, et al.
Publicado: (2020)

Neuroprotective Effects of a Small Mitochondrially-Targeted Tetrapeptide Elamipretide in Neurodegeneration
por: Nhu, Nguyen Thanh, et al.
Publicado: (2022)

Abnormalities of Mitochondrial Dynamics in the Failing Heart: Normalization Following Long-Term Therapy with Elamipretide
por: Sabbah, Hani N., et al.
Publicado: (2018)

SS-31 Provides Neuroprotection by Reversing Mitochondrial Dysfunction after Traumatic Brain Injury
por: Zhu, Yihao, et al.
Publicado: (2018)

Beneficial effects of SS-31 peptide on cardiac mitochondrial dysfunction in tafazzin knockdown mice
por: Russo, Silvia, et al.
Publicado: (2022)

Elamipretide for Barth syndrome cardiomyopathy: gradual rebuilding of a failed power grid
por: Sabbah, Hani N.
Publicado: (2021)

Natural history comparison study to assess the efficacy of elamipretide in patients with Barth syndrome
por: Hornby, Brittany, et al.
Publicado: (2022)

Elamipretide mitigates ischemia-reperfusion injury in a swine model of hemorrhagic shock
por: Patel, N., et al.
Publicado: (2023)

Identifying responders to elamipretide in Barth syndrome: Hierarchical clustering for time series data
por: Van den Eynde, Jef, et al.
Publicado: (2023)

Elamipretide reduces pyroptosis and improves functional recovery after spinal cord injury
por: Jiang, Wu, et al.
Publicado: (2023)

The mechanism of lipopolysaccharide administration-induced cognitive function impairment caused by glucose metabolism disorder in adult rats
por: Du, Yiri, et al.
Publicado: (2019)

Lipopolysaccharide-Induced Spatial Memory and Synaptic Plasticity Impairment Is Preventable by Captopril
por: Abareshi, Azam, et al.
Publicado: (2016)

Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer’s Disease
por: Calkins, Marcus J., et al.
Publicado: (2012)

Corrigendum to “Dexmedetomidine Postconditioning Alleviates Hypoxia/Reoxygenation Injury in Senescent Myocardial Cells by Regulating lncRNA H19 and m6A Modification”
por: Zhang, Xuan, et al.
Publicado: (2020)

The effects of L-arginine on spatial memory and synaptic plasticity impairments induced by lipopolysaccharide
por: Anaeigoudari, Akbar, et al.
Publicado: (2015)

Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial
por: Karaa, Amel, et al.
Publicado: (2023)

Evaluation of SS-31 as a Potential Therapeutic Target in the Treatment of Tendinopathy
por: Szeto, Hazel, et al.
Publicado: (2020)

Poster 100: Evaluation of SS-31 as a Potential Therapeutic in the Treatment of Tendinopathy
por: Szeto, Hazel, et al.
Publicado: (2022)

The cardiolipin-binding peptide elamipretide mitigates fragmentation of cristae networks following cardiac ischemia reperfusion in rats
por: Allen, Mitchell E., et al.
Publicado: (2020)

Elamipretide Improves ADP Sensitivity in Aged Mitochondria by Increasing Uptake through the Adenine Nucleotide Translocator (ANT)
por: Pharaoh, Gavin, et al.
Publicado: (2023)

Elamipretide alleviates pyroptosis in traumatically injured spinal cord by inhibiting cPLA2-induced lysosomal membrane permeabilization
por: Zhang, Haojie, et al.
Publicado: (2023)

Lentiviral-Mediated Overexpression of the 18 kDa Translocator Protein (TSPO) in the Hippocampal Dentate Gyrus Ameliorates LPS-Induced Cognitive Impairment in Mice
por: Wang, Wei, et al.
Publicado: (2016)

SS‐31 and NMN: Two paths to improve metabolism and function in aged hearts
por: Whitson, Jeremy A., et al.
Publicado: (2020)

SS-31, a Mitochondria-Targeting Peptide, Ameliorates Kidney Disease
por: Zhu, Yuexin, et al.
Publicado: (2022)

Dehydroepiandrosterone alleviates hypoxia‐induced learning and memory dysfunction by maintaining synaptic homeostasis
por: Guan, Ruili, et al.
Publicado: (2022)

Synthesis, Characterization, and Specific Localization of Mitochondrial-Targeted Antioxidant Peptide SS31 Probe
por: He, Yuan, et al.
Publicado: (2021)

Use of Elamipretide in patients assigned treatment in the compassionate use program: Case series in pediatric patients with rare orphan diseases
por: Koenig, Mary Kay, et al.
Publicado: (2022)

Development and validation of a risk nomogram for postoperative acute kidney injury in older patients undergoing liver resection: a pilot study
por: Yu, Yao, et al.
Publicado: (2022)

Endothelin-1 mediated vasoconstriction leads to memory impairment and synaptic dysfunction
por: Diwakar, Latha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p6q8gu64v5pnsqrt35qp74eoia